0001415889-24-000276.txt : 20240103 0001415889-24-000276.hdr.sgml : 20240103 20240103161518 ACCESSION NUMBER: 0001415889-24-000276 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240101 FILED AS OF DATE: 20240103 DATE AS OF CHANGE: 20240103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Russo Rene CENTRAL INDEX KEY: 0001722066 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40925 FILM NUMBER: 24506551 MAIL ADDRESS: STREET 1: C/O ARSANIS, INC. STREET 2: 890 WINTER STREET, SUITE 230 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xilio Therapeutics, Inc. CENTRAL INDEX KEY: 0001840233 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 851623397 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-833-1027 MAIL ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4-01032024_040101.xml X0508 4 2024-01-01 0001840233 Xilio Therapeutics, Inc. XLO 0001722066 Russo Rene 828 WINTER STREET SUITE 300 WALTHAM MA 02451 true true false false PRESIDENT AND CEO 0 Restricted Stock Units 2024-01-01 4 A 0 177000 0 A Common Stock 177000 177000 D Each restricted stock unit ("RSU") represents the contingent right to receive one share of the issuer's common stock. These RSUs were granted on January 1, 2024 and will vest in four equal annual installments beginning on January 1, 2025 and continuing through January 1, 2028. /s/ Christopher Frankenfield, Attorney-in-Fact 2024-01-03